Gonadotropin-independent familial sexual precocity: genes and variants
Explore variant evidence for Gonadotropin-independent familial sexual precocity across 1 analyzed protein (LHCGR). Linked ClinVar records include 12 pathogenic or likely pathogenic variants, 2 variants of uncertain significance and 6 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-15. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Gonadotropin-independent familial sexual precocity
LHCGR: Lutropin-choriogonadotropic hormone receptor
It responds to luteinizing hormone and chorionic gonadotropin to stimulate gonadal steroidogenesis, ovulation, and male sexual differentiation. Activating variants can cause male-limited precocious puberty, whereas loss-of-function variants cause Leydig-cell hypoplasia or infertility.
12 ClinVar pathogenic / likely pathogenic and 8 uncertain variants in LHCGR have source records linked to Gonadotropin-independent familial sexual precocity. Association strength is not clinical gene validity.
Where Gonadotropin-independent familial sexual precocity variants cluster
- LHCGR Transmembrane (positions 571–594): 5 of 12 ClinVar pathogenic / likely pathogenic variants, 12.1× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Gonadotropin-independent familial sexual precocity
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| LHCGR D578G | 578 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| LHCGR D564V | 564 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| LHCGR D564G | 564 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| LHCGR T577I | 577 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| LHCGR D578Y | 578 | Transmembrane | Pathogenic / likely pathogenic (★) |
| LHCGR A373V | 373 | Transmembrane | Pathogenic / likely pathogenic (★) |
| LHCGR D578N | 578 | Transmembrane | Pathogenic / likely pathogenic (★) |
| LHCGR M398T | 398 | Transmembrane | Pathogenic / likely pathogenic (★) |
| LHCGR A568V | 568 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| LHCGR L457R | 457 | Transmembrane | Pathogenic / likely pathogenic |
| LHCGR M571I | 571 | Transmembrane | Pathogenic / likely pathogenic |
| LHCGR L368P | 368 | Transmembrane | Pathogenic / likely pathogenic |
Which prediction tools work for Gonadotropin-independent familial sexual precocity
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CATVariant: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 97 out of 100
- SIFT: 90 out of 100
- AlphaMissense: 90 out of 100
Same protein, different disease
- Leydig cell agenesis also has ClinVar records linked to LHCGR variants; they fall mostly in different places as the Gonadotropin-independent familial sexual precocity variants (10 pathogenic / likely pathogenic).
Diseases related to Gonadotropin-independent familial sexual precocity
- Leydig cell agenesis, also linked to LHCGR
- Pseudohermaphroditism, also linked to LHCGR
- Leydig cell hypoplasia, also linked to LHCGR
Frequently asked questions
Which genes have records linked to Gonadotropin-independent familial sexual precocity?
This view contains 1 analyzed proteins: LHCGR. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 12 pathogenic or likely pathogenic variants, 2 variants of uncertain significance and 6 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 26 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center